Target intelligence / Profile preview

PRH1-PRR4 readthrough (PRH1-PRR4)

Target: PRH1-PRR4
Molecular classification: Long non-coding RNA (lncRNA)

Overview

PRH1-PRR4 readthrough is a long non-coding RNA transcript resulting from read-through transcription between the adjacent PRH1 and PRR4 genes on chromosome 12. It is considered a candidate for nonsense-mediated mRNA decay and is unlikely to encode any protein product. There is no evidence it serves a biological or disease-related function, nor is it therapeutically targeted or used as a biomarker.

Other names: PRH1-PRR4PRH1-PRR4 Readthrough

Mechanism of action

None (no drugs target this molecule; no mechanism of action described)

Biological functions

There is no established biological function for the PRH1-PRR4 readthrough; it is mainly noted as a readthrough event and likely targeted for decay.

Disease associations

There is no documented direct role in disease for the PRH1-PRR4 readthrough transcript specifically. Note: The individual genes (PRH1 and PRR4) have separate functions and disease associations, but not the readthrough transcript itself.

Safety considerations

None (no therapeutic interventions or challenges reported for this RNA species)

Interacting drugs

None (there are no known drugs interacting with this transcript; it does not encode a protein product)

Biomarkers

None (not used as a biomarker)

Beyond the preview

Go deeper on PRH1-PRR4 readthrough (PRH1-PRR4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRH1-PRR4 readthrough (PRH1-PRR4).

Explore the full profile